Dr Craig Belcher

Craig is Head of Life Sciences at UniQuest.

Craig has more than 20 years of deal-making and IP commercialisation experience – negotiating agreements totalling more than $100 million – including securing venture capital to establish start-up companies and licensing with major pharma and biotechnology companies based in the US, UK, Europe and Australia.

Craig serves on the board of several UniQuest portfolio companies, including Vicebio Ltd (UK), Liperate Pty Ltd and a start-up company in stealth mode. He is a past director of Dendright Pty Ltd, Nexgen Plants Pty Ltd, TenasiTech Pty Ltd and Aquahydrex Pty Ltd.

Before joining UniQuest, Craig was a Business Development Manager at Cambridge Antibody Technology and a scientist in several UK-based drug discovery start-ups. Craig has a PhD in molecular biology, an MBA and is a GAICD.